3 High-Yield Pharmaceutical Stocks
The pharmaceutical industry is a natural hunting ground for reliable income stocks, since people buy drugs in good times and in bad. But which high-yield dividend stocks are actually worthy of your investment dollars? We posed that question to a team of Motley Fool healthcare investors, and they picked Pfizer (NYSE: PFE), GlaxoSmithKline (NYSE: GSK), and Novo Nordisk (NYSE: NVO).
Image source: Getty Images.
George Budwell (Pfizer): With a yield of 3.92% at present, Pfizer offers one of the richer dividends among its big pharma peer group. But the real reason to buy this dividend stock is arguably for its staying power.
Source: Fool.com
Pfizer Inc. Stock
€27.11
1.080%
With 28 Buy predictions and 4 Sell predictions Pfizer Inc. is one of the favorites of our community.
With a target price of 41 € there is a hugely positive potential of 51.26% for Pfizer Inc. compared to the current price of 27.11 €.
